177 completed, 57 recruiting, 52 unknown, 22 not yet recruiting. 86 Not applicable, 79 Phase 3, 31 Phase 2, 24 Phase 1, 24 Phase 4.
Follow this condition Literature Review of Arthritis, Juvenile trials Research Report on Arthritis, Juvenile
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases Systemic Juvenile Idiopathic Arthritis (sJIA) | Not yet recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 9 | 2027-01-01 | 2026-03-12 | |
| Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis. Refractory Systemic Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis | Recruiting | Children's Hospital Medical Center, Cincinnati | 20 | 2026-11-01 | 2026-09-29 | |
| Pulmonary Involvement in Children With Systemic JIA Systemic Juvenile Idiopathic Arthritis, Lung Diseases | Not yet recruiting | Assiut University | 30 | 2026-10-20 | 2026-10-20 | |
| Biopsychosocial Risk Influences on the Development and Generation of Early-Onset Chronic Pain Not applicable- observational study - Juvenile Idiopathic Arthritis (JIA), Fibromyalgia | Recruiting | Children's Hospital Medical Center, Cincinnati | 600 | 2026-10-01 | 2026-10-16 | |
| Clinical Features and Treatment of Systemic JIA in Children Tocilizumab (Actemra®) - Systemic Juvenile Idiopathic Arthritis (sJIA), Systemic Juvenile Idiopathic Arthritis | Not yet recruiting | Sohag University | 50 | 2026-10-01 | 2026-09-11 | |
| Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research Pericarditis, Tako-TSUBO Cardiomyopathy | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 300 | 2026-09-01 | 2026-08-10 | |
| Pain-Sleep in Rheumatic Disease Better Nights, Better Days for Youth - Rheumatic Diseases, Arthritis | Not applicable | Not yet recruiting | The Hospital for Sick Children | 43 | 2026-09-01 | 2026-08-20 |
| A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male Participants DRL_AB - Healthy Volunteers | Phase 1 | Not yet recruiting | Dr. Reddy's Laboratories Limited | 160 | 2026-08-19 | 2026-08-04 |
| YOGA FOR CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS Telerehabilitation-Based Yoga Group, Standard Home-Based Physical Exercise Program - Juvenile Idiopathic Arthritis (JIA) | Not applicable | Completed | Akdeniz University | 32 | 2026-07-15 | 2026-10-05 |
| Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study. Juvenile Idiopathic Arthritis | Recruiting | Shanghai Jiao Tong University School of Medicine | 200 | 2026-07-01 | 2026-09-02 | |
| Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMF Juvenile Idiopathic Arthritis, Familial Mediterranean Fever | Not yet recruiting | Istanbul University - Cerrahpasa | 100 | 2026-07-01 | 2026-06-01 | |
| Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis Etanercept Optimal dosing - Juvenile Idiopathic Arthritis, Rheumatoid Arthritis | Phase 1 | Withdrawn | Duke University | 2026-07-01 | 2025-09-25 | |
| Sarcopenia and Juvenile Idiopathic Arthritis Sarcopenia screening assessment - Juvenile Idiopathic Arthritis | Not applicable | Not yet recruiting | CHU de Reims | 200 | 2026-06-01 | 2026-06-08 |
| Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents Filgotinib - Polyarticular Course Juvenile Idiopathic Arthritis | Phase 3 | Recruiting | Alfasigma S.p.A. | 65 | 2026-05-21 | 2026-06-12 |
| Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease Placebo, Goflikicept, Olokizumab - Still Disease | Phase 3 | Not yet recruiting | R-Pharm International, LLC | 52 | 2026-05-18 | 2026-06-04 |
| Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis Juvenile Idiopathic Arthritis, Tenosynovitis | Not yet recruiting | Assiut University | 106 | 2026-05-01 | 2026-04-28 | |
| OLE Study With Filgotinib in JIA Filgotinib - Juvenile Idiopathic Arthritis (JIA) | Phase 3 | Recruiting | Alfasigma S.p.A. | 80 | 2026-04-20 | 2026-08-10 |
| Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis Scoliosis | Not yet recruiting | Istanbul University | 200 | 2026-04-01 | 2026-02-27 | |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients Familial Mediterranean Fever, Still Disease | Recruiting | Novartis Pharmaceuticals | 160 | 2026-03-15 | 2026-06-09 |
Showing 20 of 355. Sign in to see all of them.
Arthritis (43) · Arthritis, Rheumatoid (31) · Lupus Erythematosus, Systemic (22) · Dermatomyositis (21) · Arthritis, Psoriatic (17) · Spondylitis, Ankylosing (14) · Motor Activity (13) · Rheumatic Diseases (12) · Scleroderma, Systemic (12) · Spondylarthritis (12) · Autoimmune Diseases (11) · Crohn Disease (11) · Still's Disease, Adult-Onset (10) · Inflammatory Bowel Diseases (9)
Skin and Connective Tissue Diseases (355) · Immune System Diseases (353) · Connective Tissue Diseases (352) · Joint Diseases (352) · Musculoskeletal Diseases (352) · Autoimmune Diseases (344) · Rheumatic Diseases (343) · Arthritis (312) · Skin Diseases (51) · Pathological Conditions, Signs and Symptoms (50) · Nervous System Diseases (45) · Bone Diseases (41) · Muscular Diseases (33) · Spinal Diseases (33) · Neuromuscular Diseases (29)
tocilizumab (24) · Etanercept (15) · Methotrexate (15) · Adalimumab (10) · canakinumab (10) · tofacitinib (8) · Abatacept (7) · Interleukin 1 Receptor Antagonist Protein (7) · secukinumab (7) · Infliximab (5) · Naproxen (5) · Blood Specimen Collection (4) · Exercise (4) · Arthroplasty, Replacement, Knee (3) · Celecoxib (3)
Novartis Pharmaceuticals (16) · Hoffmann-La Roche (13) · Istanbul University - Cerrahpasa (13) · The Hospital for Sick Children (11) · Assistance Publique - Hôpitaux de Paris (10) · Amgen (9) · Pfizer (9) · Swedish Orphan Biovitrum (8) · AbbVie (7) · Children's Hospital Medical Center, Cincinnati (6) · Sohag University (6) · University Hospital, Clermont-Ferrand (6) · Assiut University (5) · Bristol-Myers Squibb (5) · Duke University (5)
United States (106) · France (69) · Italy (55) · Canada (53) · Germany (52) · Spain (48) · Turkey (Türkiye) (47) · United Kingdom (35) · Brazil (33) · Belgium (30) · Poland (29) · Mexico (27) · Russia (27) · Argentina (25) · Netherlands (22)
Takahiro Kakehi (4) · Nuray Aktay Ayaz, Prof. Dr. (3) · Anna-Birgitte Aga, MD PhD (2) · Britt Hedenberg Magnusson, PhD DDS (2) · Carol A. Wallace, MD (2) · Dana Anaby, PhD (2)
PMID 30054164, PMID 30269054, PMID 26314396, PMID 36651601, PMID 38298058, PMID 18358927, PMID 23252526, PMID 24634205, PMID 24786929, PMID 28115015, PMID 30824645, PMID 32849606, PMID 32912276, PMID 33506875, PMID 35105709, PMID 11739431, PMID 14571231, PMID 17265499, PMID 17284544, PMID 17763439, PMID 17907238, PMID 18050186, PMID 18632147, PMID 18716298, PMID 18821668, PMID 19035501, PMID 19664754, PMID 19714630, PMID 20191582, PMID 20237125, PMID 20391508, PMID 20595280, PMID 20597110, PMID 20669280, PMID 20822542, PMID 21173013, PMID 21540203, PMID 21623000, PMID 21859696, PMID 22089462, PMID 22183975, PMID 22238240, PMID 22298793, PMID 22733975, PMID 22859354, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23053683
2023 (10), 2009 (4), 2015 (4), 2017 (4), 2018 (4), 2016 (2), 2014 (1), 2025 (1), 268200700015C-2-0-0 (1), K23AR075874 (1), N01AR422728 (1), P30NR016585 (1), P60AR044059 (1), P60AR047784 (1), R01AR049762 (1)